Aaptamine-rich Fraction from the Indonesian Marine Sponge, Aaptos suberitoides, Exhibits a Cytotoxic Effect on DLD-1

Mutia Hardhiyuna1, Ucu Yanu Arbi2, Zuraida Zuraida1

  • 1Research Center for Vaccine and Drugs, Research Organization for Health, National Research and Innovation Agency (BRIN), Jl. Raya Bogor Km.46, Cibinong, 16911, Indonesia.

Abstract

Insights

The ethyl acetate extract of the Aaptos suberitoides sponge shows promising anticancer properties. It effectively targets colorectal cancer cells (DLD-1) with greater toxicity than normal murine fibroblast cells (NIH-3T3).

Area of Science:

  • Marine Natural Products Chemistry
  • Cancer Biology
  • Drug Discovery

Background:

  • Marine sponges are a rich source of bioactive compounds.
  • Aaptos suberitoides is a marine sponge with potential pharmacological applications.
  • Colorectal cancer remains a significant global health challenge.

Purpose of the Study:

  • To evaluate the cytotoxic effects of the ethyl acetate extract of Aaptos suberitoides.
  • To assess the extract's efficacy against colorectal cancer cells (DLD-1) and normal murine fibroblast cells (NIH-3T3).

Main Methods:

  • Aaptos suberitoides was collected and extracted using ethyl acetate.
  • Extracts were analyzed using Thin Layer Chromatography (TLC) and Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LCMS/MS).
  • Cytotoxicity was determined using the MTT assay on DLD-1 and NIH-3T3 cell lines.

Main Results:

  • LCMS/MS analysis identified aaptamine as a major compound in the extract.
  • The ethyl acetate extract exhibited significant cytotoxicity against DLD-1 cells (IC50 = 9.597 µg/mL).
  • The extract was less toxic to NIH-3T3 cells (IC50 = 12.23 µg/mL), indicating selective toxicity.

Conclusions:

  • The ethyl acetate extract of Aaptos suberitoides demonstrates selective cytotoxicity towards colorectal cancer cells.
  • Aaptamine is a key compound contributing to the observed anticancer activity.
  • This extract shows potential for development as a colorectal anticancer therapeutic agent.